Therefore, we established the FFA-induced NAFLD model of HepG2 cells using 1.0 mM FFA for exploring the ameliorating activity and mechanisms of MSP1–MSP18 on NAFLD. The gene discussed is ATAD1; the disease is metabolic dysfunction-associated steatotic liver disease.